Otsuka Pharmaceutical Co. Ltd. et al v. Hetero Labs Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 11, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 506 in lead case no. 19-1938-LPS) Associated Cases: 1:19-cv-01954-LPS, 1:20-cv-01531-LPS (ntl) |
| May 11, 2022 | 16 | Patent/Trademark Report to Commissioner (7) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Nov 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01531-LPS, 387 in 1:19-cv-01938-LPS) STIPULATION and Order Regarding Partial Dismissal Without Prejudice and Consolidation. Signed by Judge Leonard P. Stark on 11/19/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01531-LPS (ntl) |
| Nov 19, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Nov 17, 2021 | 15 | Stipulation (4) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Hetero), by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Jan 14, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd) |
| Jan 6, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Kenneth S. Canfield and Dmitry V. Shelhoff for Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01531-LPS, 10 in 1:20-cv-01599-LPS) MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, Attorney Edward D. Pergament, and Attorney Dmitry V. Shelhoff filed by Hetero Labs Limited Unit-V, Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Hetero USA, Inc., Honour Lab Ltd., Hetero Labs Ltd., Hetero Drugs Ltd. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01531-LPS, 1:20-cv-01599-LPS (ntl) |
| Jan 5, 2021 | 14 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, Attorney Edward D. Pergament, and Attorney Dmitry V. Shelhoff - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd.. (Dorsney, Kenneth) |
| Dec 31, 2020 | 13 | Motion for Leave to Appear Pro Hac Vice (17) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Dec 4, 2020 | 12 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Motion by Honour Lab Ltd. re [7] MOTION to Dismiss for Failure to State a Claim (Dorsney, Kenneth) |
| Dec 3, 2020 | 11 | Answering Brief in Opposition (12) Docket Text: ANSWERING BRIEF in Opposition re [7] MOTION to Dismiss for Failure to State a Claim filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd..Reply Brief due date per Local Rules is 12/10/2020. (Balick, Steven) |
| Nov 25, 2020 | 8 | Answer to Complaint (11) Docket Text: ANSWER to [1] Complaint, by Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd..(Hitch, Cortlan) |
| Nov 25, 2020 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA, Inc. filed by Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc.. (Hitch, Cortlan) |
| Nov 25, 2020 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Honour Lab Ltd.. (Hitch, Cortlan) |
| Nov 19, 2020 | 7 | Motion to Dismiss for Failure to State a Claim (3) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Honour Lab Ltd.. (Dorsney, Kenneth) |
| Nov 18, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Nov 13, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Nov 13, 2020 | 1 | Main Document (14) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd.,Hetero Drugs Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3331208.) - filed by Otsuka Pharmaceutical Co. Ltd., H. Lundbeck. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(myr) |
| Nov 13, 2020 | 1 | Exhibit A (60) |
| Nov 13, 2020 | 1 | Civil Cover Sheet (5) |
| Nov 13, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Nov 13, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 2, 2020. Date of Expiration of Patent: April 12, 2026; pending Patent Term Extension request, when granted, extends to December 23, 2028.Thirty Month Stay Deadline: 1/10/2023. (myr) |
| Nov 13, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (myr) |
| Nov 13, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co. Ltd. filed by Otsuka Pharmaceutical Co. Ltd.. (myr) |
| Nov 13, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck. (myr) |
| Nov 13, 2020 | 1 | Complaint* (1) |
